Genetic factors associated with tuberculosis-related clinical outcomes in HIV-infected Black African patients: a systematic review and meta-analysis

Pharmacogenomics. 2021 Oct;22(15):997-1017. doi: 10.2217/pgs-2021-0096. Epub 2021 Oct 4.

Abstract

Aim: To evaluate the genetic factors influencing tuberculosis (TB) clinical outcomes in HIV-infected Black African patients. Materials & methods: We systematically searched and identified eligible publications from >550 databases indexed through February 2021. Results: Eighteen studies were included in the qualitative synthesis. Only two cohorts from one study were included in quantitative synthesis of which the low expression MIF-794 CATT5,6 (5/5 + 5/6 + 6/6) genotypes were not associated with TB infectivity in HIV-infected patients (OR: 1.31, 95% CI: 0.46-3.79). Other TB clinical outcomes observed in HIV/TB co-infected patients included: drug-induced liver injury, peripheral neuropathy, mortality, lung function and TB cure. Conclusion: This review finds inconclusive evidence that genetic factors are associated with TB clinical outcomes among HIV-infected patients in sub-Saharan Africa.

Keywords: Genetics; HIV/AIDS; meta-analysis; systematic review; tuberculosis.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Africa South of the Sahara
  • Anti-HIV Agents / therapeutic use
  • Antitubercular Agents / therapeutic use
  • Black People
  • Coinfection
  • Genotype
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / genetics*
  • Humans
  • Treatment Outcome
  • Tuberculosis / complications
  • Tuberculosis / drug therapy*
  • Tuberculosis / genetics*

Substances

  • Anti-HIV Agents
  • Antitubercular Agents